Sysmex (OTCMKTS:SSMXY) Shares Down 11.4% – Here’s Why

Sysmex Corporation ADR (OTCMKTS:SSMXY) shares were down 11.4% on Tuesday . The company traded as low as $8.35 and last traded at $8.35. Approximately 6,967 shares were traded during mid-day trading, a decline of 97% from the average daily volume of 270,783 shares. The stock had previously closed at $9.42.

Sysmex Price Performance

The stock has a fifty day moving average of $9.71 and a 200-day moving average of $11.20. The company has a quick ratio of 2.49, a current ratio of 3.34 and a debt-to-equity ratio of 0.11. The stock has a market capitalization of $5.24 billion, a price-to-earnings ratio of 17.33 and a beta of 1.14.

Sysmex (OTCMKTS:SSMXY) last announced its quarterly earnings results on Thursday, February 12th. The company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.14 by $0.01. The firm had revenue of $837.32 million for the quarter, compared to analyst estimates of $819.99 million. Sysmex had a net margin of 8.86% and a return on equity of 9.32%. On average, equities research analysts predict that Sysmex Corporation ADR will post 0.57 EPS for the current fiscal year.

Sysmex Company Profile

Sysmex Corporation (OTCMKTS: SSMXY) is a Japan‐based provider of in vitro diagnostic solutions, specializing in haematology, coagulation, urinalysis and immunochemistry systems. Headquartered in Kobe, the company designs and manufactures a comprehensive portfolio of automated analyzers, reagents and software to support clinical laboratories, hospitals and research institutions. Sysmex’s product lineup also includes digital pathology platforms and data management tools that integrate workflow automation and advanced analytics.

The company’s core offerings center on haematology analyzers such as the XN-Series, which deliver high‐speed, high‐volume testing for blood cell counts and differential analysis.